{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:31:27Z","timestamp":1786570287109,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,22]],"date-time":"2027-06-22T00:00:00Z","timestamp":1813622400000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ama121051"],"award-info":[{"award-number":["JP24ama121051"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.dmd.2026.100306","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:05:08Z","timestamp":1776726308000},"page":"100306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro assay for quantitative prediction of human intestinal drug absorption with cryopreserved human intestinal mucosal epithelium-derived intestinal stem cells and 96-well Vitrigel inserts"],"prefix":"10.1016","volume":"54","author":[{"given":"Keiichiro","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2126-2911","authenticated-orcid":false,"given":"Ryuto","family":"Tomabechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-5213","authenticated-orcid":false,"given":"Kazuya","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.dmd.2026.100306_bib1","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0090-9556(25)06742-X","article-title":"Species similarities and differences in pharmacokinetics","volume":"23","author":"Lin","year":"1995","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.dmd.2026.100306_bib2","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s11095-006-9041-2","article-title":"Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model","volume":"23","author":"Cao","year":"2006","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.dmd.2026.100306_bib3","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1002\/jps.21708","article-title":"The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans","volume":"98","author":"Takahashi","year":"2009","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmd.2026.100306_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/dmd.30.1.4","article-title":"Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas","volume":"30","author":"Nakamura","year":"2002","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2026.100306_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5173(95)04204-0","article-title":"Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo","volume":"127","author":"Lennern\u00e4s","year":"1996","journal-title":"Int J Pharm"},{"issue":"10","key":"10.1016\/j.dmd.2026.100306_bib6","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs","volume":"19","author":"Sun","year":"2002","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.dmd.2026.100306_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/dmd.121.000796","article-title":"Usefulness of human jejunal spheroid-derived differentiated intestinal epithelial cells for the prediction of intestinal drug absorption in humans","volume":"50","author":"Michiba","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmd.2026.100306_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100075","article-title":"Characterization of intestinal transporters in human ileal spheroid\u2013derived differentiated cells for the prediction of intestinal drug absorption","volume":"53","author":"Michiba","year":"2025","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100306_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2023.100532","article-title":"Establishment of human intestinal organoids derived from commercially available cryopreserved intestinal epithelium and evaluation for pharmacokinetic study","volume":"54","author":"Okada","year":"2024","journal-title":"Drug Metab Pharmacokinet"},{"issue":"11","key":"10.1016\/j.dmd.2026.100306_bib10","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1124\/dmd.118.082875","article-title":"Cryopreserved human intestinal mucosal epithelium: a novel in Vitro experimental system for the evaluation of enteric drug metabolism, cytochrome P450 induction, and enterotoxicity","volume":"46","author":"Li","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2026.100306_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejpb.2004.02.014","article-title":"Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery","volume":"58","author":"Balimane","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.dmd.2026.100306_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/2211068211428190","article-title":"Automation of cell-based drug absorption assays in 96-well format using permeable support systems","volume":"17","author":"Larson","year":"2012","journal-title":"J Lab Autom"},{"issue":"1-2","key":"10.1016\/j.dmd.2026.100306_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2005.03.008","article-title":"Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds","volume":"297","author":"Marino","year":"2005","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.dmd.2026.100306_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3727\/000000004783983882","article-title":"Collagen Vitrigel: a novel scaffold that can facilitate a three-dimensional culture for reconstructing organoids","volume":"13","author":"Takezawa","year":"2004","journal-title":"Cell Transplant"},{"key":"10.1016\/j.dmd.2026.100306_bib15","doi-asserted-by":"crossref","DOI":"10.1242\/bio.042192","article-title":"Collagen vitrigel promotes hepatocytic differentiation of induced pluripotent stem cells into functional hepatocyte-like cells","author":"Nakai","year":"2019","journal-title":"Biol Open"},{"issue":"8","key":"10.1016\/j.dmd.2026.100306_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2131\/jts.43.521","article-title":"A long-term culture system based on a collagen vitrigel membrane chamber that supports liver-specific functions of hepatocytes isolated from mice with humanized livers","volume":"43","author":"Watari","year":"2018","journal-title":"J Toxicol Sci"},{"issue":"2","key":"10.1016\/j.dmd.2026.100306_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.stemcr.2020.12.017","article-title":"Generation of human-induced pluripotent stem cell-derived functional enterocyte-like cells for pharmacokinetic studies","volume":"16","author":"Yoshida","year":"2021","journal-title":"Stem Cell Rep"},{"issue":"2","key":"10.1016\/j.dmd.2026.100306_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-1759(87)90289-4","article-title":"Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA)","volume":"103","author":"Karpinski","year":"1987","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.dmd.2026.100306_bib19","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/jm901371v","article-title":"Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination","volume":"53","author":"Varma","year":"2010","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.dmd.2026.100306_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1124\/dmd.120.000138","article-title":"Characterization of the human intestinal drug transport with using chamber system incorporating freshly isolated human jejunum","volume":"49","author":"Michiba","year":"2021","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.dmd.2026.100306_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/gutjnl-2013-306651","article-title":"Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays","volume":"64","author":"VanDussen","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.dmd.2026.100306_bib22","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"Goodman","year":"2011"},{"issue":"1-2","key":"10.1016\/j.dmd.2026.100306_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2009.05.044","article-title":"Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10","volume":"378","author":"Mizuma","year":"2009","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.dmd.2026.100306_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/cpt.2907","article-title":"Intestinal metabolism of diclofenac by polymorphic UGT2B17 correlates with its highly variable pharmacokinetics and safety across populations","volume":"114","author":"Ahire","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.dmd.2026.100306_bib25","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41591-020-1024-z","article-title":"Engineering transplantable jejunal mucosal grafts using patient-derived organoids from children with intestinal failure","volume":"26","author":"Meran","year":"2020","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.dmd.2026.100306_bib26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/dmd.118.080952","article-title":"Hepatic abundance and activity of androgen- and drug-metabolizing enzyme UGT2B17 are associated with genotype, age, and sex","volume":"46","author":"Bhatt","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.dmd.2026.100306_bib27","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1124\/dmd.105.003822","article-title":"CYP3A5 genetic polymorphisms in different ethnic populations","volume":"33","author":"Roy","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmd.2026.100306_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ajhg.2008.08.004","article-title":"Adaptive evolution of UGT2B17 copy-number variation","volume":"83","author":"Xue","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.dmd.2026.100306_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2125.2003.01712.x","article-title":"Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans","volume":"55","author":"Kirchheiner","year":"2003","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100306_bib30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002280050722","article-title":"Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9 \u2217 3 allele","volume":"56","author":"Shimamoto","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"issue":"1-2","key":"10.1016\/j.dmd.2026.100306_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/bdd.2212","article-title":"In vitro and in vivo methods to assess pharmacokinetic drug\u2013drug interactions in drug discovery and development","volume":"41","author":"Lu","year":"2020","journal-title":"Biopharm Drug Dispos"},{"issue":"5","key":"10.1016\/j.dmd.2026.100306_bib32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.apsb.2016.06.011","article-title":"A brief history of the discovery of PXR and CAR as xenobiotic receptors","volume":"6","author":"Yan","year":"2016","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"10.1016\/j.dmd.2026.100306_bib33","doi-asserted-by":"crossref","first-page":"G660","DOI":"10.1152\/ajpgi.00309.2007","article-title":"Functional characterization of PCFT\/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model","volume":"294","author":"Inoue","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dmd.2026.100306_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-nutr-072610-145133","article-title":"Mechanisms of membrane transport of folates into cells and across epithelia","volume":"31","author":"Zhao","year":"2011","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"10.1016\/j.dmd.2026.100306_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/jpet.103.063925","article-title":"Disposition mechanisms of raloxifene in the human intestinal caco-2 model","volume":"310","author":"Jeong","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.dmd.2026.100306_bib36","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.trsl.2012.03.002","article-title":"Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment","volume":"160","author":"Trdan Lu\u0161in","year":"2012","journal-title":"Transl Res"},{"issue":"8","key":"10.1016\/j.dmd.2026.100306_bib37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/CAD.0b013e328354a196","article-title":"Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance","volume":"23","author":"Sun","year":"2012","journal-title":"Anticancer Drugs"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:07:52Z","timestamp":1786568872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0090955626000759"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100306","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro assay for quantitative prediction of human intestinal drug absorption with cryopreserved human intestinal mucosal epithelium-derived intestinal stem cells and 96-well Vitrigel inserts","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100306"}}